Analyst Reco. Simulations Plus, Inc.

Equities

SLP

US8292141053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
46.32 ^USD	+2.14%		-0.71%	+3.51%

Apr. 17	InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance	CI
Apr. 04	Sector Update: Health Care Stocks Slump Late Afternoon	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Simulations Plus Insider Sold Shares Worth $798,867, According to a Recent SEC Filing	Apr. 02	MT
Oppenheimer Adjusts Simulations Plus Price Target to $55 From $67, Maintains Outperform Rating	23-10-26	MT
Oppenheimer Raises Simulations' Plus Price Target to $67 From $65, Maintains Outperform Rating	23-06-21	MT
BTIG Initiates Simulations Plus at Buy With $55 Price Target	23-05-09	MT
Sidoti Cuts Price Target on Simulations Plus to $44 From $56, Keeps Neutral Rating	22-12-22	MT
Oppenheimer Adjusts Simulations Plus Price Target to $65 From $75, Maintains Outperform Rating	22-10-27	MT
Raymond James Adjusts Price Target on Simulations Plus to $70 From $54, Keeps Outperform Rating	22-08-29	MT
Raymond James Adjusts Simulations Plus Price Target to $70 From $54, Maintains Outperform Rating	22-08-26	MT
Craig Hallum Raises Simulations Plus' Price Target to $60 From $55, Buy Rating Kept	22-07-07	MT
Simulations Plus : Berenberg Discover AI Seminar presentation, April 26, 2022 - Form 8-K	22-04-26	PU
Berenberg Discover AI Seminar	22-04-25	FA
Simulations Plus to Present at the Berenberg Discover AI Seminar	22-04-19	BU
Craig-Hallum Upgrades Simulations Plus to Buy From Hold; Price Target is $53	21-10-26	MT
SIMULATIONS PLUS : Oppenheimer Adjusts Simulations Plus PT to $75 From $85 Following Fiscal Q3 Miss, Maintains Outperform Rating	21-07-13	MT
SIMULATIONS PLUS : Craig-Hallum Adjusts Price Target on Simulations Plus to $65 From $74, Maintains Hold Rating	21-07-13	MT
SIMULATIONS PLUS : Raymond James Adjusts Price Target on Simulations Plus to $54 From $95, Keeps Outperform Rating	21-07-13	MT
SIMULATIONS PLUS : Craig-Hallum Adjusts Simulations Plus' Price Target to $74 From $81, Maintains Hold Rating	21-04-13	MT
SIMULATIONS PLUS : Oppenheimer Adjusts Price Target for Simulations Plus to $85 From $79, Maintains Outperform Rating	21-01-12	MT
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides	21-01-05	CI
SIMULATIONS PLUS : Taglich Brothers Upgrades Simulations Plus to Buy From Speculative Buy; Lifts PT to $76 From $72	20-11-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Simulations Plus, Inc.

Equities

SLP

US8292141053

Analyst Reco.

Filters